{"entity":{"type":"insider","cik":"0001579824","url":"/insider/0001579824","json_url":"/insider/0001579824.json","name":"BAUM CHARLES M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":19,"first":"2013-11-26","last":"2023-01-05","span_basis":"filed_date"},"name_variants":[{"name":"BAUM CHARLES M","source":"filing","n_filings":19,"first_seen":"2013-11-26","last_seen":"2023-01-05"}],"transactions":[{"id":8549056,"accession":"0001214659-23-000290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-23-000290","line_url":"/filing/0001214659-23-000290#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President,Founder,Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President,Founder,Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3648.0,"shares_display":"3,648","price_per_share":46.6,"price_display":"46.60","price_state":"stated","total_value":169996.8,"total_display":"169,996.80","total_whole":"169,997","shares_owned_after":168777.0,"shares_owned_after_display":"168,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":6436409,"accession":"0001214659-22-015200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-22-015200","line_url":"/filing/0001214659-22-015200#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President,Founder,Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President,Founder,Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9092.0,"shares_display":"9,092","price_per_share":40.4167,"price_display":"40.42","price_state":"stated","total_value":367468.6364,"total_display":"367,468.64","total_whole":"367,469","shares_owned_after":172425.0,"shares_owned_after_display":"172,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-21","scope":"insider"},{"id":6901721,"accession":"0001214659-22-014229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-22-014229","line_url":"/filing/0001214659-22-014229#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President,Founder,Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President,Founder,Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69256.0,"shares_display":"69,256","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":6925600.0,"total_display":"6,925,600.00","total_whole":"6,925,600","shares_owned_after":127899.0,"shares_owned_after_display":"127,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-28","scope":"insider"},{"id":6896069,"accession":"0001214659-22-000856","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-22-000856","line_url":"/filing/0001214659-22-000856#line-3","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President,Founder,Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President,Founder,Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2517.0,"shares_display":"2,517","price_per_share":120.4821,"price_display":"120.48","price_state":"stated","total_value":303253.4457,"total_display":"303,253.45","total_whole":"303,253","shares_owned_after":127899.0,"shares_owned_after_display":"127,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-18","scope":"insider"},{"id":6931192,"accession":"0001214659-22-000419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-22-000419","line_url":"/filing/0001214659-22-000419","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President,Founder,Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President,Founder,Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4114.0,"shares_display":"4,114","price_per_share":147.7527260573651,"price_display":"147.75","price_state":"stated","total_value":607854.715,"total_display":"607,854.72","total_whole":"607,855","shares_owned_after":101239.0,"shares_owned_after_display":"101,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-06","scope":"insider","n_lines":2},{"id":5385897,"accession":"0001214659-21-012712","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001214659-21-012712","line_url":"/filing/0001214659-21-012712","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President & Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47204.0,"shares_display":"47,204","price_per_share":133.20242904203033,"price_display":"133.20","price_state":"stated","total_value":6287687.4605,"total_display":"6,287,687.46","total_whole":"6,287,687","shares_owned_after":129209.0,"shares_owned_after_display":"129,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-03","scope":"insider","n_lines":7},{"id":5210293,"accession":"0001214659-21-006762","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001214659-21-006762","line_url":"/filing/0001214659-21-006762","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":165.4558150375,"price_display":"165.46","price_state":"stated","total_value":6618232.6015,"total_display":"6,618,232.60","total_whole":"6,618,233","shares_owned_after":113737.0,"shares_owned_after_display":"113,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-21","scope":"insider","n_lines":4},{"id":4107112,"accession":"0001214659-21-000332","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-000332","line_url":"/filing/0001214659-21-000332","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4511.0,"shares_display":"4,511","price_per_share":210.38931877632453,"price_display":"210.39","price_state":"stated","total_value":949066.217,"total_display":"949,066.22","total_whole":"949,066","shares_owned_after":87512.0,"shares_owned_after_display":"87,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-08","scope":"insider","n_lines":2},{"id":3133250,"accession":"0001214659-20-010598","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001214659-20-010598","line_url":"/filing/0001214659-20-010598","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":234.477839255,"price_display":"234.48","price_state":"stated","total_value":9379113.5702,"total_display":"9,379,113.57","total_whole":"9,379,114","shares_owned_after":109203.0,"shares_owned_after_display":"109,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-21","scope":"insider","n_lines":7},{"id":2977782,"accession":"0001214659-20-003519","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-20-003519","line_url":"/filing/0001214659-20-003519","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":90.327719195,"price_display":"90.33","price_state":"stated","total_value":3613108.7678,"total_display":"3,613,108.77","total_whole":"3,613,109","shares_owned_after":110756.0,"shares_owned_after_display":"110,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-17","filed_date":"2020-04-20","scope":"insider","n_lines":3},{"id":8214544,"accession":"0001214659-19-005436","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001214659-19-005436","line_url":"/filing/0001214659-19-005436","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51810.0,"shares_display":"51,810","price_per_share":86.2248925805829,"price_display":"86.22","price_state":"stated","total_value":4467311.6846,"total_display":"4,467,311.68","total_whole":"4,467,312","shares_owned_after":77562.0,"shares_owned_after_display":"77,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-22","filed_date":"2019-08-23","scope":"insider","n_lines":6},{"id":8170072,"accession":"0001214659-19-001618","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001214659-19-001618","line_url":"/filing/0001214659-19-001618","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51810.0,"shares_display":"51,810","price_per_share":75.6740321598147,"price_display":"75.67","price_state":"stated","total_value":3920671.6062,"total_display":"3,920,671.61","total_whole":"3,920,672","shares_owned_after":92129.0,"shares_owned_after_display":"92,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider","n_lines":5},{"id":5969626,"accession":"0001214659-18-005702","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-18-005702","line_url":"/filing/0001214659-18-005702","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51810.0,"shares_display":"51,810","price_per_share":57.55237204400695,"price_display":"57.55","price_state":"stated","total_value":2981788.3956,"total_display":"2,981,788.40","total_whole":"2,981,788","shares_owned_after":52794.0,"shares_owned_after_display":"52,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-24","scope":"insider","n_lines":3},{"id":6143697,"accession":"0001214659-18-001631","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-18-001631","line_url":"/filing/0001214659-18-001631","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51810.0,"shares_display":"51,810","price_per_share":28.03431285852152,"price_display":"28.03","price_state":"stated","total_value":1452457.7492,"total_display":"1,452,457.75","total_whole":"1,452,458","shares_owned_after":59618.0,"shares_owned_after_display":"59,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-23","filed_date":"2018-02-27","scope":"insider","n_lines":2},{"id":6102214,"accession":"0001562180-18-000727","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-18-000727","line_url":"/filing/0001562180-18-000727#line-3","is_derivative":false,"issuer_cik":"0001100412","issuer_name":"ARRAY BIOPHARMA INC","issuer_ticker":"ARRY","issuer_name_source":null,"issuer_url":"/issuer/0001100412","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":16.9,"price_display":"16.90","price_state":"stated","total_value":845000.0,"total_display":"845,000.00","total_whole":"845,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-09","filed_date":"2018-02-12","scope":"insider"},{"id":4596477,"accession":"0001562180-17-001360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-17-001360","line_url":"/filing/0001562180-17-001360#line-2","is_derivative":false,"issuer_cik":"0001100412","issuer_name":"ARRAY BIOPHARMA INC","issuer_ticker":"ARRY","issuer_name_source":null,"issuer_url":"/issuer/0001100412","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":9.27,"price_display":"9.27","price_state":"stated","total_value":231750.0,"total_display":"231,750.00","total_whole":"231,750","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-28","filed_date":"2017-03-30","scope":"insider"},{"id":3287380,"accession":"0001190725-16-000428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001190725-16-000428","line_url":"/filing/0001190725-16-000428#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":7.0535,"price_display":"7.05","price_state":"stated","total_value":141070.0,"total_display":"141,070.00","total_whole":"141,070","shares_owned_after":48556.0,"shares_owned_after_display":"48,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-14","filed_date":"2016-06-14","scope":"insider"},{"id":8918520,"accession":"0001127602-15-017039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-017039","line_url":"/filing/0001127602-15-017039#line-2","is_derivative":false,"issuer_cik":"0001100412","issuer_name":"ARRAY BIOPHARMA INC","issuer_ticker":"ARRY","issuer_name_source":null,"issuer_url":"/issuer/0001100412","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":7.3793,"price_display":"7.38","price_state":"stated","total_value":184482.5,"total_display":"184,482.50","total_whole":"184,483","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-08","filed_date":"2015-05-12","scope":"insider"},{"id":5512544,"accession":"0001209191-13-054179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-054179","line_url":"/filing/0001209191-13-054179#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001579824","owner_name":"BAUM CHARLES M","owner_display_name":"BAUM CHARLES M","owner_url":"/insider/0001579824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":16.9638,"price_display":"16.96","price_state":"stated","total_value":84819.0,"total_display":"84,819.00","total_whole":"84,819","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-11-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":50,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":48,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":50},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Director, Officer (President,Founder,Head of R&D)","n_filings":16,"first_seen":"2013-11-26","last_seen":"2023-01-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001100412","name":"ARRAY BIOPHARMA INC","url":"/issuer/0001100412","role":"Director","n_filings":3,"first_seen":"2015-05-12","last_seen":"2018-02-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001579824","retrieved_at":"2026-08-22T22:25:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}